Advertisement
Canada markets close in 4 hours 21 minutes
  • S&P/TSX

    21,651.78
    -88.42 (-0.41%)
     
  • S&P 500

    5,056.09
    -5.73 (-0.11%)
     
  • DOW

    37,835.68
    +100.57 (+0.27%)
     
  • CAD/USD

    0.7233
    -0.0020 (-0.28%)
     
  • CRUDE OIL

    85.55
    +0.14 (+0.16%)
     
  • Bitcoin CAD

    85,937.92
    -3,251.48 (-3.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,395.80
    +12.80 (+0.54%)
     
  • RUSSELL 2000

    1,965.63
    -10.08 (-0.51%)
     
  • 10-Yr Bond

    4.6510
    +0.0230 (+0.50%)
     
  • NASDAQ

    15,878.54
    -6.48 (-0.04%)
     
  • VOLATILITY

    18.56
    -0.67 (-3.48%)
     
  • FTSE

    7,817.04
    -148.49 (-1.86%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6805
    -0.0019 (-0.28%)
     

India $10.19 Billion Dietary Supplement Markets, Competition, Forecast & Opportunities, FY2026

Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "India Dietary Supplement Market, By Product Type (Vitamin, Mineral, Combination Dietary Supplement, Herbal Supplement, Fish Oil & Omega Fatty Acid, & Other), By Form, By Distribution Channel, By Application, By End Use, BY Region, Competition, Forecast & Opportunities, FY2026" report has been added to ResearchAndMarkets.com's offering.

The Indian Dietary Supplement Market was valued USD 3924.44 Million in FY2020 and is predicted to grow at CAGR of 17.28% until FY2026, to reach USD 10,198.57 Million by FY2026.

Anticipated growth in the market can be attributed to growing consumer awareness about preventive healthcare, increasing purchasing power and rising cases of lifestyle diseases such as obesity, blood pressure, diabetes, malnutrition, etc. In addition, adoption of aggressive marketing & promotional strategies for the promotion of dietary supplement is expected to positively influence the growth of the market.

Consumers are increasingly shifting towards preventive healthcare. India has one of the highest diabetes cases in the world and it is anticipated that over 80 million people will be diabetic in the country by 2030. Consumers are now getting increasingly aware about excessive use of chemicals and their side effects and opting for dietary supplements. This changing trend would boost the country's dietary supplement market.

In FY2020, combination dietary supplement held the lion's share in market due to owing to the fact that vitamin & mineral dietary supplement contain a variety of micronutrients, water-soluble & fat-soluble vitamins that help the body to function smoothly and improve mental health as well. Based on distribution channel, pharmacies & drug stores led the market with share of 64.49% in FY2020 as the government licenses them to sell drugs and dietary supplements as prescribed by doctors or health professionals.

The Indian Dietary Supplement Market is controlled by several major players, including Abbott India Limited, Herbalife International India Pvt. Ltd., Amway India Enterprises Pvt. Ltd., Dabur India Limited, Danone Nutricia International Pvt. Ltd., Himalaya Drug Company, GlaxoSmithKline Consumer Healthcare Ltd., Sun Pharmaceutical Industries Ltd., Kraft Heinz India Pvt. Ltd., and Patanjali Ayurved Limited, among others.

Companies operating in the market are investing in R&D and launching new products to retain their share in the competitive market.

Key Target Audience:

  • Manufacturers and suppliers of vitamin & mineral dietary supplements, herbal dietary supplements, protein dietary supplements & other dietary supplements

  • Organizations, forums and alliances related to dietary supplements

  • Industry associations and government bodies such as regulating authorities and policy makers

ADVERTISEMENT

Years considered for this report:

  • Historical Years: FY2016-FY2019

  • Base Year: FY2020

  • Estimated Year: FY2021

  • Forecast Period: FY2022-FY2026

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on India Dietary Supplement Market

5. India Dietary Supplement Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Vitamin, Mineral, Combination Dietary Supplement, Herbal Supplement, Fish Oil & Omega Fatty Acid, Protein & Other)
5.2.2. By Form (Tablets, Capsules, Powder, Liquids, Soft Gels)
5.2.3. By Distribution Channel (Pharmacies and Drug Stores, Supermarkets and Hypermarkets, Online, Others)
5.2.4. By Application (Energy & Weight Management, General Health, Bone & Joint Health, Immunity Others)
5.2.5. By End Use (Infants, Children, Adults, Pregnant Females, Geriatric)
5.2.6. By Region
5.2.7. By Company
5.3. Product Market Map

6. North India Dietary Supplement Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Form
6.2.3. By Distribution Channel
6.2.4. By Application
6.2.5. By End Use

7. South India Dietary Supplement Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Form
7.2.3. By Distribution Channel
7.2.4. By Application
7.2.5. By End Use

8. East India Dietary Supplement Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Form
8.2.3. By Distribution Channel
8.2.4. By Application
8.2.5. By End Use

9. West India Dietary Supplement Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Form
9.2.3. By Distribution Channel
9.2.4. By Application
9.2.5. By End Use

10. Import & Export Analysis

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Policy & Regulatory Landscape

14. India Economic Profile

15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.2.1. Amway India Enterprises Private Limited
15.2.2. Herbalife International India Private Limited
15.2.3. Dabur India Limited
15.2.4. Abbott India Limited
15.2.5. Kraft Heinz India Private Limited
15.2.6. Himalaya Drug Company
15.2.7. Sun Pharmaceutical Industries Limited
15.2.8. GlaxoSmithKline Consumer Healthcare Limited
15.2.9. Danone Nutricia International Private Limited
15.2.10. Patanjali Ayurved Limited

16. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/k0oxhw

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900